|
Hemostasis, Thrombosis, and Vascular Biology
Citations 311-320 of 2496 total displayed.
|
Past content
(since Jan 1997):
|
Regulation of macrophage procoagulant responses by the tissue factor cytoplasmic domain in endotoxemia
- Jasimuddin Ahamed, Frank Niessen, Toru Kurokawa, Young Kyung Lee, Gourab Bhattacharjee, James H. Morrissey, and Wolfram Ruf
Blood 2007; 109: 5251-5259.
[Abstract]
[Full text]
[PDF]
Ligand density dramatically affects integrin IIbß3-mediated platelet signaling and spreading
- Markéta Jirousková, Jyoti K. Jaiswal, and Barry S. Coller
Blood 2007; 109: 5260-5269.
[Abstract]
[Full text]
[PDF]
Fatal hemorrhage in mice lacking -glutamyl carboxylase
- Aihua Zhu, Hongmin Sun, Richard M. Raymond, Jr, Barbara C. Furie, Bruce Furie, Mila Bronstein, Randal J. Kaufman, Randal Westrick, and David Ginsburg
Blood 2007; 109: 5270-5275.
[Abstract]
[Full text]
[PDF]
Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer
- Mary Anna Venneri, Michele De Palma, Maurilio Ponzoni, Ferdinando Pucci, Cristina Scielzo, Erika Zonari, Roberta Mazzieri, Claudio Doglioni, and Luigi Naldini
Blood 2007; 109: 5276-5285.
[Abstract]
[Full text]
[PDF]
The effect of a single nucleotide polymorphism on human 2-antiplasmin activity
- Victoria J. Christiansen, Kenneth W. Jackson, Kyung N. Lee, and Patrick A. McKee
Blood 2007; 109: 5286-5292.
[Abstract]
[Full text]
[PDF]
New thrombopoietic growth factors
- David J. Kuter
Blood 2007; 109: 4607-4616.
[Abstract]
[Full text]
[PDF]
Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study
- Samantha C. Gouw, Johanna G. van der Bom, and H. Marijke van den Berg, for the CANAL Study group
Blood 2007; 109: 4648-4654.
[Abstract]
[Full text]
[PDF]
Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study
- Samantha C. Gouw, Johanna G. van der Bom, Günter Auerswald, Carmen Escuriola Ettinghausen, Ulf Tedgård, and H. Marijke van den Berg, for the CANAL Study group
Blood 2007; 109: 4693-4697.
[Abstract]
[Full text]
[PDF]
Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist
- Julian M. Jenkins, Daphne Williams, Yanli Deng, Joanne Uhl, Valerie Kitchen, David Collins, and Connie L. Erickson-Miller
Blood 2007; 109: 4739-4741.
[Abstract]
[Full text]
[PDF]
Lack of endothelial cell survivin causes embryonic defects in angiogenesis, cardiogenesis, and neural tube closure
- Femke Zwerts, Florea Lupu, Astrid De Vriese, Saskia Pollefeyt, Lieve Moons, Rachel A. Altura, Yuying Jiang, Patrick H. Maxwell, Peter Hill, Hideyasu Oh, Claus Rieker, Désiré Collen, Simon J. Conway, and Edward M. Conway
Blood 2007; 109: 4742-4752.
[Abstract]
[Full text]
[PDF]
|
|